These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24641191)

  • 41. Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin.
    Anderson-Crannage M; Ascensión AM; Ibanez-Solé O; Zhu H; Schaefer E; Ottomanelli D; Hochberg B; Pan J; Luo W; Tian M; Chu Y; Cairo MS; Izeta A; Liao Y
    Front Immunol; 2023; 14():1211505. PubMed ID: 37809094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
    Ortiz-Urda S; Garcia J; Green CL; Chen L; Lin Q; Veitch DP; Sakai LY; Lee H; Marinkovich MP; Khavari PA
    Science; 2005 Mar; 307(5716):1773-6. PubMed ID: 15774758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
    Perdoni C; Osborn MJ; Tolar J
    Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.
    Titeux M; Pendaries V; Zanta-Boussif MA; Décha A; Pironon N; Tonasso L; Mejia JE; Brice A; Danos O; Hovnanian A
    Mol Ther; 2010 Aug; 18(8):1509-18. PubMed ID: 20485266
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Liemberger B; Bischof J; Ablinger M; Hainzl S; Murauer EM; Lackner N; Ebner P; Kocher T; Nyström A; Wally V; Mayr E; Guttmann-Gruber C; Hofbauer JP; Bauer JW; Koller U
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa.
    So JY; Nazaroff J; Yenamandra VK; Gorell ES; Harris N; Fulchand S; Eid E; Dolorito JA; Marinkovich MP; Tang JY
    J Am Acad Dermatol; 2024 Sep; 91(3):448-456. PubMed ID: 38735484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa.
    Bremer J; Kramer D; Eichhorn DS; Gostyński A; Diercks GFH; Jonkman MF; van den Akker PC; Pasmooij AMG
    Exp Dermatol; 2019 Oct; 28(10):1153-1155. PubMed ID: 30019435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa.
    Wang X; Alshehri F; Manzanares D; Li Y; He Z; Qiu B; Zeng M; A S; Lara-Sáez I; Wang W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.
    Ito K; Sawamura D; Goto M; Nakamura H; Nishie W; Sakai K; Natsuga K; Shinkuma S; Shibaki A; Uitto J; Denton CP; Nakajima O; Akiyama M; Shimizu H
    Am J Pathol; 2009 Dec; 175(6):2508-17. PubMed ID: 19893033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel and very rare causative variants in the COL7A1 gene of Vietnamese patients with recessive dystrophic epidermolysis bullosa revealed by whole-exome sequencing.
    Ma THT; Luong TLA; Hoang TL; Nguyen TTH; Vu TH; Tran VK; Nguyen DB; Trieu TS; Nguyen HH; Nong VH; Nguyen DT
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1748. PubMed ID: 34286919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
    Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
    J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
    Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
    Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
    Chung HJ; Uitto J
    Dermatol Clin; 2010 Jan; 28(1):93-105. PubMed ID: 19945621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
    Dang N; Klingberg S; Marr P; Murrell DF
    J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
    Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
    J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs.
    Osborn MJ; Newby GA; McElroy AN; Knipping F; Nielsen SC; Riddle MJ; Xia L; Chen W; Eide CR; Webber BR; Wandall HH; Dabelsteen S; Blazar BR; Liu DR; Tolar J
    J Invest Dermatol; 2020 Feb; 140(2):338-347.e5. PubMed ID: 31437443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
    Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
    J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa.
    Atanasova VS; Jiang Q; Prisco M; Gruber C; Piñón Hofbauer J; Chen M; Has C; Bruckner-Tuderman L; McGrath JA; Uitto J; South AP
    J Invest Dermatol; 2017 Sep; 137(9):1842-1849. PubMed ID: 28549954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
    Primerano A; De Domenico E; Cianfarani F; De Luca N; Floriddia G; Teson M; Cristofoletti C; Cardarelli S; Scaglione GL; Baldini E; Cangelosi D; Uva P; Reinoso Sánchez JF; Roubaty C; Dengjel J; Nyström A; Mastroeni S; Ulisse S; Castiglia D; Odorisio T
    Br J Dermatol; 2024 Sep; 191(4):568-579. PubMed ID: 38820176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes.
    Supp DM; Hahn JM; Combs KA; McFarland KL; Schwentker A; Boissy RE; Boyce ST; Powell HM; Lucky AW
    Cell Transplant; 2019; 28(9-10):1242-1256. PubMed ID: 31271052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.